To more accurately replicate the pathological milieu of osteoarthritis, we utilized an integrated approach combining in vitro mechanistic studies with in vivo validation in the DMM mouse model. In vitro experiments focused on evaluating the direct effects of EVs on bone-cartilage interface metabolism under normal physiological conditions, without introducing inflammatory stimuli such as IL-1β. The gene discussed is IL1B; the disease is osteoarthritis.